Sutro Biopharma (NASDAQ:STRO) reported its Q2 earnings results on Monday, August 8, 2022 at 04:30 PM.
Here’s what investors need to know about the announcement.
Earnings
Sutro Biopharma missed estimated earnings by 19.57%, reporting an EPS of $-0.55 versus an estimate of $-0.46.
Revenue was up $47 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 5.96% increase in the share price the next day.
Here’s a look at Sutro Biopharma’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.76 | -0.69 | -0.65 | -0.41 |
| EPS Actual | -0.84 | -0.83 | -0.67 | -0.13 |
| Revenue Estimate | 10.47M | 10.65M | 8.97M | 13.34M |
| Revenue Actual | 5.90M | 10.65M | 8.52M | 28.05M |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Sutro Biopharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
